Biodesix Inc (BDSX) - Product Pipeline Analysis, 2024 Update

Biodesix Inc (Biodesix) discovers, develops and commercializes testing solutions for lung Diseases. The company's services include diagnostic test and biopharma services. Its Biopharma services include biomarker discovery and development, companion diagnostic partnering and clinical trial support and testing. It markets its products under the brand names including GeneStrat, VeriStrat, Nodify Lung and IQLung. Biodesix’s product portfolio includes GeneStrat, a gene panel of clinically actionable mutations for tumor profiling for patients with advanced lung cancer and VeriStrat, a serum proteomic test for patients with non-small cell lung cancer. Biodesix is headquartered in Boulder, Colorado, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
The report analyzes all pipeline products in development for the company Biodesix Inc
The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
The report provides detailed description of products in development, technical specification and functions
The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.

Reasons to Buy:

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
To formulate effective Research & Development strategies
Develop market-entry and market expansion strategies
Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

Biodesix Inc Company Overview
Biodesix Inc Company Snapshot
Biodesix Inc Pipeline Products and Ongoing Clinical Trials Overview
Biodesix Inc - Pipeline Analysis Overview
Biodesix Inc - Key Facts
Biodesix Inc - Major Products and Services
Biodesix Inc Pipeline Products by Development Stage
Biodesix Inc Pipeline Products Overview
52-Gene Panel Based Companion Diagnostic
52-Gene Panel Based Companion Diagnostic Product Overview
AI-Based Algorithm - COVID-19
AI-Based Algorithm - COVID-19 Product Overview
Biodesix Collection Device (BCD)
Biodesix Collection Device (BCD) Product Overview
Companion Diagnostic Test - NSCLC
Companion Diagnostic Test - NSCLC Product Overview
HIV Diagnostic Test
HIV Diagnostic Test Product Overview
HRM-MS Based Companion Diagnostic Test
HRM-MS Based Companion Diagnostic Test Product Overview
Multiplexed Proteomic Assay - Alzheimer’s Disease
Multiplexed Proteomic Assay - Alzheimer’s Disease Product Overview
Next Generation Based Minimal Residual Disease Assay
Next Generation Based Minimal Residual Disease Assay Product Overview
PD-L1 Blood Based Diagnostic Test
PD-L1 Blood Based Diagnostic Test Product Overview
TAm-Seq NGS Lung Cancer Test
TAm-Seq NGS Lung Cancer Test Product Overview
VeriStrat - Breast Cancer
VeriStrat - Breast Cancer Product Overview
VeriStrat - Colorectal Cancer
VeriStrat - Colorectal Cancer Product Overview
Biodesix Inc - Key Competitors
Biodesix Inc - Key Employees
Biodesix Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Biodesix Inc, Recent Developments
May 21, 2024: Biodesix to Present New Data on the Nodify XL2 Test at ATS 2024 Annual Meeting
May 21, 2024: Biodesix to Present New Data on the Nodify XL2® Test at ATS 2024 Annual Meeting
Apr 09, 2024: Biodesix to Present New Data on Liquid Biopsy Technologies at AACR 2024 Annual Meeting
Nov 14, 2023: Biodesix Enhances Access to Nodify Lung Testing with Launch of New Blood Draw Method
Oct 03, 2023: Biodesix to Present New Data on Nodify Lung Testing at Chest 2023 Annual Meeting
Sep 07, 2023: Biodesix Announces Two Presentations on Lung Cancer Treatment Guidance Tests at the IASLC 2023 World Lung Conference on Lung Cancer
Sep 05, 2023: Biodesix to Participate in Two Upcoming Investor Conferences in September
Aug 22, 2023: Biodesix Announces Presentation of New Nodify XL2 Data at AABIP Conference Highlighting Increased Proportion of Biopsies Diagnosing Cancer
Jul 12, 2023: Biodesix Announces Publication of the ORACLE Clinical Utility Study with the Primary Endpoint Demonstrating that the Nodify XL2 Test Reduced Unnecessary Invasive Procedures on Benign Lung Nodules
Jul 06, 2023: Biodesix Awarded Advanced Diagnostic Laboratory Test Status for its Nodify CDT Test by the Center for Medicare and Medicaid Services
Appendix
Methodology
About the Analyst
Contact the Publisher
Disclaimer

List of Tables

Biodesix Inc Pipeline Products and Ongoing Clinical Trials Overview
Biodesix Inc Pipeline Products by Equipment Type
Biodesix Inc Pipeline Products by Indication
Biodesix Inc, Key Facts
Biodesix Inc, Major Products and Services
Biodesix Inc Number of Pipeline Products by Development Stage
Biodesix Inc Pipeline Products Summary by Development Stage
52-Gene Panel Based Companion Diagnostic - Product Status
52-Gene Panel Based Companion Diagnostic - Product Description
AI-Based Algorithm - COVID-19 - Product Status
AI-Based Algorithm - COVID-19 - Product Description
Biodesix Collection Device (BCD) - Product Status
Biodesix Collection Device (BCD) - Product Description
Companion Diagnostic Test - NSCLC - Product Status
Companion Diagnostic Test - NSCLC - Product Description
HIV Diagnostic Test - Product Status
HIV Diagnostic Test - Product Description
HRM-MS Based Companion Diagnostic Test - Product Status
HRM-MS Based Companion Diagnostic Test - Product Description
Multiplexed Proteomic Assay - Alzheimer’s Disease - Product Status
Multiplexed Proteomic Assay - Alzheimer’s Disease - Product Description
Next Generation Based Minimal Residual Disease Assay - Product Status
Next Generation Based Minimal Residual Disease Assay - Product Description
PD-L1 Blood Based Diagnostic Test - Product Status
PD-L1 Blood Based Diagnostic Test - Product Description
TAm-Seq NGS Lung Cancer Test - Product Status
TAm-Seq NGS Lung Cancer Test - Product Description
VeriStrat - Breast Cancer - Product Status
VeriStrat - Breast Cancer - Product Description
VeriStrat - Colorectal Cancer - Product Status
VeriStrat - Colorectal Cancer - Product Description
Biodesix Inc, Key Employees
Biodesix Inc, Subsidiaries
Glossary

List of Figures

Biodesix Inc Pipeline Products by Equipment Type
Biodesix Inc Pipeline Products by Development Stage

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

Roka Bioscience Inc
Foundation Medicine Inc
Cardiocom LLC